The intervening effects of mycophenolate mofetil on CD34+ hematopoietic cells in bone marrow of asthma mice

H. Mao, K. Yin (Nanjing, China)

Source: Annual Congress 2005 - Therapy in allergic airway disease
Session: Therapy in allergic airway disease
Session type: Thematic Poster Session
Number: 921
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Mao, K. Yin (Nanjing, China). The intervening effects of mycophenolate mofetil on CD34+ hematopoietic cells in bone marrow of asthma mice. Eur Respir J 2005; 26: Suppl. 49, 921

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Results of switch from mycophenolate mofetil to azathioprin after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004

Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002

Mycophenolate mofetil reduces alveolar inflammation and acute rejection and improves overall outcome after lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006

Cyclosporine A, FK506, mycophenolate mofetil, and prednisolone differentially modulate interleukin-8 release of bronchial epithelial cells
Source: Eur Respir J 2002; 20: Suppl. 38, 571s
Year: 2002

Lung function 5 yrs after allogeneic bone marrow transplantation conditioned with busulphan and cyclophosphamide
Source: Eur Respir J 2004; 23: 901-905
Year: 2004



The anti-asthmatic mechanisms and effect of interfering expression of IL 5 Rα on the differentiation of bone marrow CD34+ progenitors of asthma mice
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006

Safety and effectiveness of mycophenolate mofetil in interstitial lung diseases
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Impact of mycophenolate mofetil on lung function in chronic hypersensitivity pneumonitis and connective tissue disease related-ILD
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


Can mycophenolate mofetil 15 mg/kg/day attenuate experimental pulmonary fibrosis in rats?
Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis
Year: 2009


Use of mycophenolate mofetil for the treatment of hypersensitivity pneumonitis>
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020


The effects of glucocorticoid and Cys LT1 receptor antagonist on CD34+ cells in bone marrow of asthmatic mice
Source: Eur Respir J 2004; 24: Suppl. 48, 349s
Year: 2004

Mycophenolate mofetil and azathioprine in chronic hypersensitivity pneumonitis
Source: International Congress 2016 – Orphan diseases I
Year: 2016

Long term azithromycin use for bronchiolitis obliterans in ten allogeneic hematopoietic stem cell transplant recipients
Source: Annual Congress 2008 - Lung and bone marrow transplantation: miscellaneous
Year: 2008


Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003

Human pulmonary arterial hypertension bone marrow-derived CD133+ myeloid progenitors induce vascular remodeling in immunodeficient mice
Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension
Year: 2011

Bone marrow progenitor cells in patients with COPD
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010

HGF expressing stem cells in usual interstitial pneumonia originate from the bone marrow and are antifibrotic
Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Year: 2014


Effects of bone marrow mononuclear cell therapy in an experimental model of silicosis
Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Year: 2008


In vivo chracterization of bone marrow derived progenitor cells in airway remodeling in murine asthma model
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007


Effects of bone marrow mesenchymal stem cells on bleomycin induced pulmonary fibrosis in rats
Source: Annual Congress 2006 - Pulmonary fibrosis: pathophysiology and therapeutic approaches
Year: 2006